Cargando…
A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model
Neuroblastoma (NB) is a pediatric malignancy characterized by a marked reduction in aerobic energy metabolism. Recent preclinical data indicate that targeting this metabolic phenotype by a ketogenic diet (KD), especially in combination with calorie restriction, slows tumor growth and enhances metron...
Autores principales: | Aminzadeh-Gohari, Sepideh, Feichtinger, René Günther, Vidali, Silvia, Locker, Felix, Rutherford, Tricia, O’Donnel, Maura, Stöger-Kleiber, Andrea, Mayr, Johannes Adalbert, Sperl, Wolfgang, Kofler, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630289/ https://www.ncbi.nlm.nih.gov/pubmed/29029389 http://dx.doi.org/10.18632/oncotarget.20041 |
Ejemplares similares
-
The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome
por: Vidali, Silvia, et al.
Publicado: (2017) -
Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model
por: Morscher, Raphael Johannes, et al.
Publicado: (2015) -
Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model
por: Morscher, Raphael Johannes, et al.
Publicado: (2016) -
Ketogenic diet in the treatment of cancer – Where do we stand?
por: Weber, Daniela D., et al.
Publicado: (2019) -
Untargeted Metabolomics Reveals Molecular Effects of Ketogenic Diet on Healthy and Tumor Xenograft Mouse Models
por: Licha, David, et al.
Publicado: (2019)